- Quarterly
- Annual
- TTM
-
Export .csv
-
Download Image
-
Copy link
-
Embed code
Share URL
Bar Chart preview
Merck & Co., Inc. Revenue Year-on-Year (YoY) growth is 4.10% for the Trailing 12 Months (TTM) ending March 31, 2025. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period. Year-on-Year (YoY) growth is the change in a financial metric compared to the same period in the previous year, expressed as a percentage. Merck & Co., Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 61.40 B, a 6.11% change year over year. Merck & Co., Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 57.87 B, a 7.21% change year over year. Merck & Co., Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 53.98 B, a 24.30% change year over year. Merck & Co., Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 43.42 B, a -9.69% change year over year.
StockViz
Embed chart view
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max